U.S. Pharmaceuticals & Biotech Most Popular Stocks

PTC Therapeutics

Market Cap: US$4.7b

A biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

Krystal Biotech

Market Cap: US$4.7b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Alkermes

Market Cap: US$4.6b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Arrowhead Pharmaceuticals

Market Cap: US$4.5b

Develops medicines for the treatment of intractable diseases in the United States.

Sotera Health

Market Cap: US$4.5b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

Arcellx

Market Cap: US$4.4b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Jyong Biotech

Market Cap: US$4.3b

A science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia.

Vaxcyte

Market Cap: US$4.3b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Protagonist Therapeutics

Market Cap: US$4.1b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Akero Therapeutics

Market Cap: US$3.8b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Kymera Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

ADMA Biologics

Market Cap: US$3.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Mirum Pharmaceuticals

Market Cap: US$3.7b

A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

Zai Lab

Market Cap: US$3.6b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Soleno Therapeutics

Market Cap: US$3.4b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

MoonLake Immunotherapeutics

Market Cap: US$3.4b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Crinetics Pharmaceuticals

Market Cap: US$3.3b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Ligand Pharmaceuticals

Market Cap: US$3.3b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Scholar Rock Holding

Market Cap: US$3.2b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

uniQure

Market Cap: US$3.2b

Develops treatments for patients suffering from rare and other devastating diseases in the United States.

Centessa Pharmaceuticals

Market Cap: US$3.2b

A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.

Prestige Consumer Healthcare

Market Cap: US$3.1b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Amneal Pharmaceuticals

Market Cap: US$3.0b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Mineralys Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States.

NewAmsterdam Pharma

Market Cap: US$3.0b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Viking Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Perrigo

Market Cap: US$2.9b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Procaps Group

Market Cap: US$2.9b

Develops, produces, and markets pharmaceutical solutions in South America, Central America, North America, and Europe.

Apellis Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Indivior

Market Cap: US$2.9b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Xenon Pharmaceuticals

Market Cap: US$2.8b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

CG Oncology

Market Cap: US$2.8b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Ultragenyx Pharmaceutical

Market Cap: US$2.8b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Organon

Market Cap: US$2.7b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Immunovant

Market Cap: US$2.7b

A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.